Skip to main content
. Author manuscript; available in PMC: 2009 Nov 18.
Published in final edited form as: Curr Chem Genomics. 2009 Jan 1;3(1):7–12. doi: 10.2174/1875397300903010007

Table 1.

Summary of compound potencies (μM) with known activity in the CREB pathway identified from screening of the LOPAC library in qHTS

Name First Run Second Run Third Run Mean ± SD
Forskolin 0.32 0.25 0.25 0.27±0.04
8-(4-Chlorophenylthio)-cAMP 25.12 25.12 15.85 22.03±5.35
8-Bromo-cAMP 25.12 15.85 25.12 22.03±5.35
Papaverine hydrochloride 1.58 0.79 0.79 1.06±0.46
Trequinsin (HL-725) 2.51 1.58 1.26 1.79±0.65
Rolipram 1.26 1.26 2.00 1.50±0.43
Ro 20-1724 5.01 12.59 2.00 6.53±5.46
Etazolate hydrochloride 12.59 15.85 15.85 14.76±1.88
Ibudilast 10.00 12.59 12.59 11.73±1.49
Tracazolate 5.01 5.01 5.01 5.01±0.00
T-1032 12.59 12.59 12.59 12.59±0.00
3-Isobutyl-1-methylxanthine 15.85 15.85 15.85 15.85±0.00
8-Methoxymethyl-3-isobutyl-1-methylxanthine 25.12 15.85 15.85 18.94±5.35
Propentofylline 25.12 25.12 15.85 22.03±5.35
Zardaverine 10.00 15.85 12.59 12.81±2.93